Suggested Dosing
Herpes Simplex Labialis
1000 mg PO qD-TID x 6-12 months
Topical: (Super Lysine Plus) applied q2hr x11days
Metabolic Alkalosis
10 g PO qDay divided doses for up to 5 days
Next:
Suggested Uses
Athletic performance enhancement, herpes simplex labialis, metabolic alkalosis
Efficacy
Possibly effective for herpes simplex labialis treatment
Previous
Next:
Adverse Effects
Diarrhea, abdominal pain, chronic renal failure, interstitial nephritis
Previous
Next:
Warnings
Contraindications
None reported
Cautions
Kidney disease
Previous
Next:
Pregnancy & Lactation
Pregnancy Category: avoid use
Lactation: avoid use
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Previous
Next:
Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
Lysine inhibits replication of arginine-rich herpes viruses
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
